Pushing the boundaries of behavioral analysis could aid psychiatric drug discovery

PLoS Biol. 2022 Dec 8;20(12):e3001904. doi: 10.1371/journal.pbio.3001904. eCollection 2022 Dec.

Abstract

Drug discovery for psychiatric conditions is stagnating. Behavioral changes could be used as a primary phenotypic screen for new drug candidates, if enough useful data can be generated from behavioral models. Could machine learning be the answer to extracting the data we need?

MeSH terms

  • Drug Discovery*

Grants and funding

The authors received no specific funding for this work.